Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's disease

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects:implications for Parkinson's disease

Eoin O'Neill

Andrew Harkin

Keywords：noradrenalinemicrogliaastrocytesinflammationParkinson's diseaseneuroprotectionanimal modeldopamie

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 1332-1337 )

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2018,13(8)